Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS · Delayed Price · Currency is USD
1.550
0.00 (0.00%)
May 6, 2026, 1:13 PM EST
HRGN Market Cap
HRGN has a market cap or net worth of $27.25 million as of May 6, 2026. Its market cap has decreased by -46.26% in one year.
Market Cap
27.25M
Enterprise Value
26.10M
Revenue
704.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.55
Market Cap Chart
Since October 21, 2013, HRGN's market cap has decreased from 48.00M to 27.25M, a decrease of -43.23%. That is a compound annual growth rate of -4.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 27.25M | -13.74% |
| Dec 31, 2025 | 31.59M | -33.41% |
| Dec 30, 2024 | 47.44M | -31.84% |
| Dec 29, 2023 | 69.60M | 3.94% |
| Dec 30, 2022 | 66.96M | 170.54% |
| Dec 31, 2021 | 24.75M | 110.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProText Mobility | 55.38M |
| Vicapsys Life Sciences | 47.26M |
| Provectus Biopharmaceuticals | 24.06M |
| Arch Biopartners | 21.88M |
| Anebulo Pharmaceuticals | 18.76M |
| Oncotelic Therapeutics | 16.74M |
| Inhibitor Therapeutics | 15.53M |
| Zeo ScientifiX | 15.36M |